
S03 E16: Pharma review of the year 2022
EMJ GOLD: Pharma news, views and analysis
00:00
COVID-19 - The Challenge of the Year
Four experts share their views on the impact of COVID-19. Novo Nordisk's Robert Grimm emphasises the importance of digital transformation in aiding its recovery. Paul Simms, CEO of Impatient Health offers another perspective on how the industry has responded to the challenge as his challenge of the year.
Play episode from 07:49
Transcript


